MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 42 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $583,000 | +19.2% | 583,000 | 0.0% | 0.00% | – |
| Q1 2019 | $489,000 | +1937.5% | 583,000 | +1666.7% | 0.00% | – |
| Q4 2018 | $24,000 | -97.0% | 33,000 | -96.1% | 0.00% | – |
| Q1 2018 | $813,000 | -87.3% | 847,000 | -87.9% | 0.00% | -100.0% |
| Q4 2017 | $6,395,000 | -75.0% | 6,995,000 | -71.2% | 0.00% | -77.8% |
| Q3 2017 | $25,571,000 | +54.6% | 24,325,000 | +53.9% | 0.02% | +50.0% |
| Q2 2017 | $16,535,000 | – | 15,805,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |